Topical treatment adherence and associated factors in patients with psoriasis: A single center, cross-sectional study

Dermatol Ther. 2022 Jul;35(7):e15547. doi: 10.1111/dth.15547. Epub 2022 May 11.

Abstract

Topical medications are one of the main treatments for psoriasis. Adherence to treatment is an important factor in achieving successful control of disease. The aim of this study was to evaluate adherence to topical drugs and identify possible associated factors in in patients with psoriasis. Ninety-three patients were evaluated by a two-part questionnaire; the first part examined demographic, socioeconomic and disease-related factors while the second part, the ECOB questionnaire (Elaboration d'un outil d'evaluation de l'observance des traitements medicamenteux), examined adherence to topical drugs. The mean self-reported adherence to topical treatment in this study, was 50.5%. Severe disease, involvement of lower extremity, and positive family history of psoriasis were associated with poor adherence to treatment. Patients with a history of diabetes mellitus had better adherence to treatment. In this study adherence to topical treatment was low and had no significant relationship with most of the studied demographic and socioeconomic factors.

Keywords: administration; medication adherence; outcome assessment; patient compliance; psoriasis; topical.

MeSH terms

  • Administration, Topical
  • Cross-Sectional Studies
  • Dermatologic Agents*
  • Humans
  • Medication Adherence
  • Psoriasis* / diagnosis
  • Psoriasis* / drug therapy
  • Treatment Adherence and Compliance

Substances

  • Dermatologic Agents